Hello, everyone, and how are you today? We are just fine, thank you, especially since a warm and shiny sun is hovering over the Pharmalot campus. Moreover, our short person has successfully left for the local schoolhouse and the official mascots are contentedly snoozing in their corners. As for us, we are quaffing cups of stimulation — white chocolate cranberry is our choice today — and foraging for interesting items. Speaking of which, here are a few to get you started. Hope your day goes well and keep us in mind when you hear something juicy …

U.S. Supreme Court justices on Monday appeared divided over whether a process used for challenging patents violates the constitutional rights of patent owners, Reuters reports. At issue is a dispute over the U.S. Patent and Trademark Office’s patent review proceeding, known as inter partes review. A decision to strike down the reviews could fundamentally change the way patent disputes are litigated in the U.S.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy